Estimaciones de analistas de Wall Street para aTyr Pharma, Inc. (ATYR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 3 |
| Mantener | 7 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 10 |
| Calificación media (1-5) | 0.30 |
Ratios de valoración
| Precio / Valor contable | 0.72 |
| EV / EBITDA | -1.02 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | $422000 | $10.5M | 0 | $10.4M | $353000 | $235000 | $190000 |
| Coste de Ventas | $900000 | $713000 | $746000 | $14.0M | $17.3M | $1.3M | $1.7M | 0 | 0 | $1.6M |
| Beneficio Bruto | -$900000 | -$713000 | -$746000 | -$13.6M | -$6.8M | -$1.3M | $8.7M | $353000 | $235000 | -$1.4M |
| I+D | $44.2M | $30.1M | $20.4M | $14.0M | $17.3M | $23.3M | $42.8M | $42.3M | $54.4M | $60.2M |
| Generales y Administrativos | $14.2M | $16.4M | $11.7M | $9.4M | $9.1M | $10.8M | $12.3M | $13.0M | $13.8M | $17.6M |
| Gastos Operativos | $58.4M | $46.4M | $32.1M | $9.4M | $9.1M | $32.7M | $55.1M | $55.3M | $68.1M | $76.3M |
| Beneficio Operativo | -$59.3M | -$47.1M | -$32.8M | -$23.0M | -$15.9M | -$34.0M | -$46.4M | -$54.9M | -$67.9M | -$77.6M |
| EBITDA | -$57.0M | -$46.4M | -$32.1M | -$22.3M | -$14.6M | -$32.5M | -$43.6M | -$47.7M | -$62.5M | -$72.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$57.9M | -$48.2M | -$34.5M | -$23.8M | -$16.2M | -$33.8M | -$45.3M | -$50.4M | -$64.0M | -$74.1M |
| Impuestos | -$49000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$57.9M | -$48.2M | -$34.5M | -$23.6M | -$16.2M | -$33.8M | -$45.3M | -$50.4M | -$64.0M | -$74.1M |
| BPA | $-34.20 | $-26.16 | $-16.13 | $-7.03 | $-1.77 | $-1.77 | $-1.60 | $-0.94 | $-0.86 | $-0.80 |
| BPA Diluido | $-34.20 | $-26.16 | $-16.13 | $-7.03 | $-1.77 | $-1.77 | $-1.60 | $-0.94 | $-0.86 | $-0.80 |
| Acciones en Circulación (Diluidas) | $1.7M | $1.8M | $2.1M | $3.4M | $9.2M | $19.1M | $28.4M | $53.6M | $74.3M | $93.0M |
Precio
| Precio | $0.38 |
| Capitalización | $38M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACRV · ALXO · CAMP · DTIL · HYFT · MGX · QNCX
Explorar sector: Healthcare · Biotechnology
Más secciones de ATYR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones